Efficacy of DHMEQ, a NF-κB Inhibitor, in Islet Transplantation

Abstract

Inhibition of NF-κB activation by DHMEQ after PITx reduces the HMGB1-triggered proinflammatory responses and results in engraftment of transplanted islets even with fewer islet grafts.